Closing of the acquisition of a majority stake in a consultancy business active in the pharmaceutical industry.

Jacquemoud Stanislas represented the acquirer, which is backed by a large French private equity firm, in the acquisition of such majority stake.

The team included Philippe Jacquemoud and Alexandre Salem.